Balancing benefits and harms in public health prevention programmes mandated by governments
- 1 July 2004
- Vol. 329 (7456) , 41-43
- https://doi.org/10.1136/bmj.329.7456.41
Abstract
Introduction The principal rationale for medical research is to improve health. In clinical medicine, the goal is to get the results of medical research to individual patients as soon as possible. In preventive medicine, however, the challenge is to apply clinical and epidemiological evidence to whole populations. The most effective way to do this is through government legislation. However, once a government requires an intervention, individuals may have little chance to influence whether they are exposed to it. This means that government decisions to require prevention measures are political. Unless the decision is anchored securely in science, even weak political arguments can over-rule the science and the needs of public health. We consider the challenges that face the introduction and maintenance of evidence based public health interventions using the current debates over preventing birth defects by fortification of flour with folic acid and the safety of the MMR (measles, mumps, and rubella) vaccine.1 2Keywords
This publication has 10 references indexed in Scilit:
- Do Vaccines Cause Harm? The Need for Open-Minded Analysis Based on Science and ReasonAdvances in Pediatrics, 2003
- Inertia on folic acid fortification: Public health malpracticeTeratology, 2002
- Insufficient folic acid intake in the Netherlands: What about the future?Teratology, 2002
- Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube DefectsJAMA, 2001
- Folic acid and the prevention of disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy.2000
- Trends in serum folate after food fortificationThe Lancet, 1999
- Lowered Risks of Hypertension and Cerebrovascular Disease after Vitamin/Mineral Supplementation: The Linxian Nutrition Intervention TrialAmerican Journal of Epidemiology, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.1991